What's New at Charles River
   
 
 
   
   

Model Evaluation Program Now Includes p53 and Bcrp TGEM® Knockout Rats

April 12, 2012 - Available exclusively from Charles River, receive an evaluation order of the p53 or Bcrp TGEM® knockout rat models as part of the Charles River Model Evaluation Program, implemented to provide you a risk-free, cost-effective way of determining if our models are right for your research. To place your order, complete our Model Evaluation Request Form.

Overview of Models

The p53 TGEM® knockout rat [Crl:WI(UL)-Tp53m1/Hubr] develops a variety of malignant tumors, including sarcomas and lymphomas. This model’s tumor onset and mortality statistics improve timelines for carcinogenicity testing. To learn more, click here.

The Bcrp TGEM® knockout rat [Crl:WI(UL)-Abcg2m1/Hubr] carries a mutation within the catalytic center ABC transporter-like domain of the rat Abcg2 (BCRP) gene, eliminating all wild-type protein. In vivo drug transport studies conducted in this rat model will enhance the ability to predict how drug candidates will perform in humans. To learn more, click here.

For more information about the p53 or Bcrp TGEM® knockout rats or questions on placing an evaluation order, please contact us at askcharlesriver@crl.com.  

Related Information

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Apr 11 - Access New and Updated Clinical Pa...
Mar 20 - TARGATT™ Mouse for Reliable Target...
Jun 10-Jun 13 - Barcelona, Spain - FELASA - SECAL 2013
May 28-Jun 01 - Kobe, Japan - Joint Meeting of the International Bone and Mineral Socie...
May 27-May 29 - Almere, The Netherlands - Rodent Surgery Hands-on Training (3-day)

Charles River Laboratories, Inc.